Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Sep
10
2021
Beltway Buzz, September 10, 2021: Vaccine Mandate; Federal Employment Law Changes Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
10
2021
Biden Administration Unveils Sweeping Workplace Vaccination Plan Mintz
Sep
10
2021
Locally Sourced Cannabis Laws: The Importance of Zoning in Cannabis Operations Womble Bond Dickinson (US) LLP
Sep
10
2021
White House Announces New Measures to Fight COVID-19 Pandemic Miller Canfield
Sep
10
2021
OSHA and CMS to Require Employers to Mandate Vaccines or Weekly Negative Tests Squire Patton Boggs (US) LLP
Sep
10
2021
White House Announces Vaccination Mandate or Weekly Testing for Large Employers, and Vaccination Mandate for Federal Employees and Contractors ArentFox Schiff LLP
Sep
10
2021
Let's Talk Hemp: Highlights from the 2021 Southern Hemp Expo Ward and Smith, P.A.
Sep
9
2021
Coming Soon: Employers Required To Ensure Employees Are Vaccinated Or Regularly Tested – President Biden’s Sweeping COVID-19 Action Plan: What Employers Need to Know (US) Squire Patton Boggs (US) LLP
Sep
9
2021
Federal Circuit Reiterates Requirement under § 287 that Alleged Infringers have Notice of Specific Alleged Infringement Mintz
Sep
9
2021
Federal Circuit Vaporizes Pre-Suit Damages Bradley Arant Boult Cummings LLP
Sep
9
2021
Recall Roundup: August 2021 Hunton Andrews Kurth
Sep
9
2021
Competition Currents | September 2021 | The Netherlands | United Kingdom | Poland Italy | European Union Greenberg Traurig, LLP
Sep
9
2021
Competition Currents | September 2021 | United States | Mexico Greenberg Traurig, LLP
Sep
9
2021
Another Genus Claim Bites the Dust for Lack of Written Description McDermott Will & Emery
Sep
9
2021
The Fast Track: Using Blockchain to Trace Products Through the Supply Chain Foley & Lardner LLP
Sep
8
2021
Withheld Prior Art and Inconsistent Arguments Used to Obtain FDA Approval Renders Patent Unenforceable Finnegan
Sep
8
2021
USDA Asked to Modernize Poultry Safety Standards Keller and Heckman LLP
Sep
7
2021
New York City Passes More City-Level Privacy Legislation Squire Patton Boggs (US) LLP
Sep
7
2021
Cannabusiness Divorces: Seeing Green, Not Red Bradley Arant Boult Cummings LLP
Sep
7
2021
ANPR on Labeling Cell-Cultured Products Published Keller and Heckman LLP
Sep
7
2021
CDC Issues New COVID-19 Vaccination Requirements for Green Card Applicants Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
7
2021
New York and Chicago-Style Pizza Wars: The Trademark Edition Proskauer Rose LLP
Sep
3
2021
Japan is Contemplating the Future of Cell-based Meats Keller and Heckman LLP
Sep
3
2021
McDermottPlus Check-Up: Medicare Finances Report & CMS Directors: Sept 3, 2021 McDermott Will & Emery
Sep
3
2021
Belmora Petitions for Supreme Court Review of FLANAX Decision Norris McLaughlin P.A.
Sep
2
2021
7 Things To Do (and 7 Not To Do) During an FDA Investigation Oberheiden P.C.
Sep
2
2021
After the Recall: A Framework for Recovery Womble Bond Dickinson (US) LLP
Sep
2
2021
Prop 12 Prevails over Constitutionality Complaints Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins